Results 41 to 50 of about 4,965 (233)

Delayed-Onset Malignant Hyperthermia in Association with Rocuronium Use [PDF]

open access: yes, 2012
Purpose Two cases of malignant hyperthermia suspected to be related to the use of a nondepolarizing neuromuscular blocker are reported. Summary A pharmacogenetic disorder that may occur in as many as 1 in 3000 anesthesia procedures, malignant ...
Beggs, Ashton E.   +2 more
core   +2 more sources

Malignant hyperthermia [PDF]

open access: yesKorean Journal of Anesthesiology, 2012
Malignant hyperthermia (MH) is an uncommon, life-threatening pharmacogenetic disorder of the skeletal muscle. It presents as a hypermetabolic response in susceptible individuals to potent volatile anesthetics with/without depolarizing muscle relaxants ...
Dong-Chan Kim
doaj   +1 more source

Targeting cellular calcium homeostasis to prevent cytokine-mediated beta cell death [PDF]

open access: yes, 2017
Pro-inflammatory cytokines are important mediators of islet inflammation, leading to beta cell death in type 1 diabetes. Although alterations in both endoplasmic reticulum (ER) and cytosolic free calcium levels are known to play a role in cytokine ...
Abreu, Damien   +9 more
core   +2 more sources

Binding of dantrolene sodium to muscle intracellular membranes [PDF]

open access: yesFEBS Letters, 1980
Dantrolene sodium (l- { [5-@-nitrophenyl)furfuryl- idene]amino}hydantoin sodium was synthesized in 1967 [I] and later shown to act as a depressant of muscle contractility. It has proven to be effective in the treatment of various forms of spasticity [2] as well as in the prophylaxis and treatment of the potentially lethal malignant hyperthermia muscle ...
Ernesto Carafoli   +2 more
openaire   +3 more sources

In vivo Ca2+ dynamics induced by Ca2+ injection in individual rat skeletal muscle fibers [PDF]

open access: yes, 2017
Citation: Wakizaka, M., Eshima, H., Tanaka, Y., Shirakawa, H., Poole, D. C., & Kano, Y. (2017). In vivo Ca2+ dynamics induced by Ca2+ injection in individual rat skeletal muscle fibers. Physiological Reports, 5(5), 10.
Eshima, H.   +5 more
core   +1 more source

Electropermeabilization of inner and outer cell membranes with microsecond pulsed electric field. Quantitative study with calcium ions [PDF]

open access: yes, 2017
Microsecond pulsed electric fields (mu sPEF) permeabilize the plasma membrane (PM) and are widely used in research, medicine and biotechnology. For internal membranes permeabilization, nanosecond pulsed electric fields (nsPEF) are applied but this ...
Andrã©, Franck M.   +4 more
core   +2 more sources

Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma

open access: yesJournal of Anaesthesiology Clinical Pharmacology, 2016
Soma (Carisoprodol) is N-isopropyl-2 methyl-2-propyl-1,3-propanediol dicarbamate; a commonly prescribed, centrally acting skeletal muscle relaxant. Neuroleptic malignant syndrome (NMS) is a potentially life-threatening adverse effect of antipsychotic ...
Gunchan Paul   +2 more
doaj   +1 more source

Effects of extracellular Ca++, K+, and Na+ on cone and retinal pigment epithelium retinomotor movements in isolated teleost retinas. [PDF]

open access: yes, 1984
We have examined the effects of changes in extracellular ionic composition on cone and retinal pigment epithelium (RPE) retinomotor movements in cultured isolated teleost retinas.
BURNSIDE, Beth, Dearry, A
core   +4 more sources

A Case of Fatal Malignant Hyperthermia During Pes Equinovarus Surgery in a Child

open access: yesJournal of Pediatric Emergency and Intensive Care Medicine, 2018
Malignant hyperthermia (MH) is a genetic syndrome characterized by hyperthermia, tachycardia, acidosis, and muscle rigidity, often triggered by depolarizing muscle relaxants such as volatile anesthetics and/or succinylcholine.
Ümüt Altuğ   +5 more
doaj   +1 more source

Progesterone analogue protects stressed photoreceptors via bFGF-mediated calcium influx. [PDF]

open access: yes, 2016
Retinitis pigmentosa (RP) is a degenerative retinal disease leading to photoreceptor cell loss. In 2011, our group identified the synthetic progesterone ‘Norgestrel’ as a potential treatment for RP.
Byrne, Ashleigh M.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy